
ticalenta 90mg Tablet
Marketer
Astra Labs
Salt Composition
Ticagrelor (90mg)
Overview ticalenta 90mg Tablet
CardioGuard 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in patients with cardiac conditions. CardioGuard 90mg is also indicated for individuals recovering from a recent heart attack, experiencing severe angina (chest pain), or following coronary stenting. Its purpose is to mitigate the risk of subsequent cardiac events, including further heart attacks, strokes, or clot formation within stents. Concurrently, your physician will likely prescribe aspirin, another antiplatelet medication. CardioGuard 90mg can be ingested with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as discontinuation raises the risk of recurrent cardiac events. The most frequent adverse effect is bleeding; injuries may bleed more profusely and for extended periods. While typically mild and self-resolving, persistent or excessive bleeding should be reported. Some patients experience mild shortness of breath, usually subsiding with ongoing treatment; however, worsening or persistent breathlessness warrants medical attention. CardioGuard 90mg is contraindicated in individuals with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Always inform your doctor of any pre-existing conditions before commencing treatment.
Uses of ticalenta 90mg Tablet
Avoiding heart attacks and strokes
Major Benefits of ticalenta 90mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticalenta 90mg tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of ticalenta 90mg Tablet:
- Bleeding
- Breathlessness
How to use ticalenta 90mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 90mg ticalenta tablet should be swallowed whole; do not crush, chew, or break it. While it can be taken with or without food, consistency is key—take it at the same time each day.
How ticalenta 90mg Tablet works:
Ticagrelor 90mg tablets are a type of antiplatelet agent. Their mechanism of action involves inhibiting platelet aggregation, thus reducing the risk of dangerous clot development. This, in turn, diminishes the likelihood of experiencing a heart attack or stroke.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining alcohol and ticalenta 90mg tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Ticalenta 90mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 90mg ticalenta tablets with breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticalenta 90mg tablets.
KidneySAFE IF PRESCRIBED
Ticalenta 90mg tablets are considered safe for patients with kidney impairment; no dosage modification is advised. Data regarding ticalenta 90mg tablet use in individuals undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ticalenta 90mg tablets, as dose modification may be necessary. Severe hepatic dysfunction contraindicates the use of Ticalenta 90mg tablets; physician consultation is advised.
What if you forget to take ticalenta 90mg Tablet :
Should you forget a dose of your 90mg Ticalenta tablet, take it immediately. But, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About ticalenta 90mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Triazolopyrimidine derivatives |
| Potential for Dependence | None. |
| Medication Category | Hematological |
| Mechanism of Action | Blockers of the P2Y12 ADP receptor |
